Rising demand for gene and cell therapies, expanding mRNA vaccine pipelines, and increasing investments in GMP-compliant manufacturing facilities are driving growth in the viral vectors and plasmid ...

A new clinical trial demonstrates that hepatocyte growth factor plasmid therapy with AMG0001 is a promising, nonsurgical ...

Inovio Pharmaceuticals ( ($INO) ) has provided an announcement. On December 29, 2025, INOVIO announced that the U.S. Food and Drug Administration ...

Antibiotic resistance is a major global health threat, complicating the treatment of common infections. This PhD thesis explored how antibiotic resistance spreads beyond the farm environment, linking ...

Twist Bioscience (TWST) just rolled out research grade Plasmid DNA Preps tailored for pre clinical pharma and biotech work, a small but telling move that helps explain the recent uptick in the stock.

TheFly reported on December 15 that Barclays raised its price target for TWST from $37 to $39 while maintaining an Overweight ...

This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...

Thermo Fisher Scientific Inc. has introduced Gibco Bacto CD Supreme FPM Plus and Gibco Bacto CD Supreme Feed (2X).

2025, A Year of Momentum: Advancing Toward a Potential Breakthrough in Ovarian Cancer Treatment ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of Gibco™ Bacto™ CD Supreme FPM Plus and Gibco™ Bacto™ CD Supreme Feed (2X), two next-generation ...

A postdoctoral researcher at Indiana University has been federally charged after allegedly using women’s underwear shipments ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of Gibco(TM) Bacto(TM) CD Supreme FPM Plus and Gibco(TM) Bacto(TM) CD Supreme Feed (2X), two ...